留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

口服缓控释微丸的研究进展

陈婷 张倩 宋洪涛

陈婷, 张倩, 宋洪涛. 口服缓控释微丸的研究进展[J]. 药学实践与服务, 2011, 29(3): 169-172,192.
引用本文: 陈婷, 张倩, 宋洪涛. 口服缓控释微丸的研究进展[J]. 药学实践与服务, 2011, 29(3): 169-172,192.
CHEN Ting, ZHANG Qian, SONG Hong-tao. Progress of oral sustained-release and controlled-release pellets[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(3): 169-172,192.
Citation: CHEN Ting, ZHANG Qian, SONG Hong-tao. Progress of oral sustained-release and controlled-release pellets[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(3): 169-172,192.

口服缓控释微丸的研究进展

Progress of oral sustained-release and controlled-release pellets

  • 摘要: 目的 综述近年来国内外缓控释微丸的研究进展,并展望微丸制剂的发展前景。 方法 查阅相关文献,并将其分析、归纳。 结果 阐明了不同种类缓控释微丸的特点、所选用的辅料、制备工艺及微丸压片技术。 结论 微丸作为一种多单元释药系统,具有较多优点,随着现代制备工艺的逐渐成熟及辅料的发展,微丸成为目前缓控释制剂发展的重要方向。
  • [1] 马 萍,孙淑英,辛艳茹,等.硝苯地平海藻酸钙凝胶缓释微丸处方及工艺的优化[J].沈阳药科大学学报,2003,20(6):406.
    [2] 郑建津,沈慧风.卡波普在口服缓释制剂中的应用概况[J].中国药学杂志,2002,37(2):84.
    [3] Krause J,Thommes M,Breitkreutz J.Immediate release pellets with lipid binders obtained by solvent-free cold extrusion[J].Eur J Pharm Biopharm,2009,71:138.
    [4] Cheboyina S,Wyandt CM.Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics[J].Int J Pharm,2008,359(1-2):158.
    [5] Cheboyina S,Wyandt CM.Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms[J].Int J Pharm, 2008,359(1-2):167.
    [6] Young CR, Koleng JJ,McGinity JW.Production of spherical pellets by a hot-melt extrusion and spheronization process[J].Int J Pharm,2002,242(1-2):87.
    [7] Young CR,Dietzsch C,McGinity JW.Compression of controlled-release pellets produced by a hot-melt extrusion and spheronization process[J].Pharm Dev Technol,2005,10(1):133. [8] 刘 扬,张 玮,袁 臻,等.去甲斑蝥素骨架型缓释微丸的工艺优化[J].中国医院药学杂志,2008,28(15):1243. [9] 陈大为,张彦青,邹艳霜,等.灯盏花素缓释微丸制备工艺与处方优化的研究[J].中草药,2003,34(11):990.[10] 蔡翠芳,毕殿洲,毛世瑞.挤出滚圆法制备氢溴酸右美沙芬骨架缓释微丸[J].沈阳药科大学学报,2003,20(5):313.[11] 关世侠,杨 民,李海刚,等.非诺贝特缓释微丸的制备及释放度研究[J].中国医院药学杂志,2008,28(9):712.[12] Kramar A,Turk S,Vrecer F.Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films[J].Int J Pharm,2003,256(1-2):43.[13] Siepmann F,Hoffmann A,Leclercq B,et al.How to adjust desired drug release patterns from ethylcellulose-coated dosage forms[J].J Controlled Release,2007,119:182.[14] Muschert S,Siepmann F,Leclercq B,et al.Drug release mechanisms from ethylcellulose: PVA-PEG graft copolymer-coated pellets[J].Eur J Pharm Biopharm,2009,72:130.[15] Serratoni M,Newton M,Booth S,et al.Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system[J].Eur J Pharm Biopharm,2007,65:94.[16] Sriamornsak P,Kennedy RA.Effect of drug solubility on release behavior of calcium polysaccharide gel-coated pellets[J].Eur J Pharm Sci,2007,32(3):231. [17] Podczeck F, Knight PE, Newton JM.The evaluation of modified microcrystalline cellulose for the preparation of pellets with high drug loading by extrusion/spheronization[J].Int J Pharm,2008,350:145. [18] Roblegg E,Ulbing S,Zeissmann S,et al.Development of lipophilic calcium stearate pellets using ibuprofen as model drug[J].Eur J Pharm Biopharm,2010,75(1):56.[19] Dukic'-Ott A,Thommes M,Remon JP,et al.Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: A critical review[J].Eur J Pharm Biopharm,2009,71:38.[20] Sousa J,Sousa A,Moura J,et al.The influence of core materials and film coating on the drug release from coated pellets[J].Int J Pharm,2002,233(1/2):111.[21] Sriamornsak P,Burton MA,Kennedy RA.Development of polysaccharide gel coated pellets for oral administration 1. Physico-mechanical properties[J].Int J Pharm,2006,326(1-2):80. [22] Abdul S,Chandewar A,Jaiswal S.A flexible technology for modified-release drugs: Multiple-unit pellet system (MUPS)[J].J Controlled Release,2010,147(1):2.
  • [1] 陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾.  基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 479-486. doi: 10.12206/j.issn.2097-2024.202401073
    [2] 陈金涛, 乔子婴, 马明华, 张若曦, 王振伟, 年华.  基于网络药理学和分子对接技术研究金芪清疏颗粒治疗社区获得性肺炎的潜在机制 . 药学实践与服务, 2024, 42(11): 471-478. doi: 10.12206/j.issn.2097-2024.202312014
    [3] 张莲卿, 骆岩, 杨提, 姚佳晨, 李文艳.  基于FAERS数据库的艾塞那肽微球不良事件信号挖掘与研究 . 药学实践与服务, 2024, 42(10): 445-450. doi: 10.12206/j.issn.2097-2024.202403057
    [4] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
  • 加载中
计量
  • 文章访问数:  3237
  • HTML全文浏览量:  267
  • PDF下载量:  165
  • 被引次数: 0
出版历程
  • 收稿日期:  2010-09-15
  • 修回日期:  2010-12-21

口服缓控释微丸的研究进展

摘要: 目的 综述近年来国内外缓控释微丸的研究进展,并展望微丸制剂的发展前景。 方法 查阅相关文献,并将其分析、归纳。 结果 阐明了不同种类缓控释微丸的特点、所选用的辅料、制备工艺及微丸压片技术。 结论 微丸作为一种多单元释药系统,具有较多优点,随着现代制备工艺的逐渐成熟及辅料的发展,微丸成为目前缓控释制剂发展的重要方向。

English Abstract

陈婷, 张倩, 宋洪涛. 口服缓控释微丸的研究进展[J]. 药学实践与服务, 2011, 29(3): 169-172,192.
引用本文: 陈婷, 张倩, 宋洪涛. 口服缓控释微丸的研究进展[J]. 药学实践与服务, 2011, 29(3): 169-172,192.
CHEN Ting, ZHANG Qian, SONG Hong-tao. Progress of oral sustained-release and controlled-release pellets[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(3): 169-172,192.
Citation: CHEN Ting, ZHANG Qian, SONG Hong-tao. Progress of oral sustained-release and controlled-release pellets[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(3): 169-172,192.
参考文献 (7)

目录

    /

    返回文章
    返回